Evolving ibogaine treatment
The ibogaine narrative is off, and the industry has a standards problem.
The New York Times article from August 2026 looked at the ibogaine industry in Mexico and found a lot of problems.
- The 80 to 90% Trump and Rogan quoted has left a wake of disappointment
- Short stays, other psychedelics within days, zero cultural connection
- Overmedicated clients, underperforming experiences, undisclosed doses




